These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of steroid hormone receptors with respect to tumor cellularity. Geppert M; Smyczek-Gargya B; Dietl J; Schneider H Zentralbl Pathol; 1993 Aug; 139(3):217-9. PubMed ID: 8218122 [TBL] [Abstract][Full Text] [Related]
6. Biclonal breast carcinoma metastatic to a supraclavicular lymph node. Cimbaluk D; Usha L; Siziopikou KP Breast J; 2005; 11(6):488. PubMed ID: 16297106 [No Abstract] [Full Text] [Related]
7. Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing. Hede K J Natl Cancer Inst; 2008 Jun; 100(12):836-7, 844. PubMed ID: 18544732 [No Abstract] [Full Text] [Related]
8. Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review. Langel DJ; Yeatts RP; White WL Am J Dermatopathol; 2001 Oct; 23(5):444-9. PubMed ID: 11801778 [TBL] [Abstract][Full Text] [Related]
9. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781 [TBL] [Abstract][Full Text] [Related]
10. [Biological features of breast cancer in patients under 35]. Damenia AO; Turkevich EA; Semiglazov VF; Kochetova IA; Gurbanov SS; Bit-Sava EM; Efimenko AV Vopr Onkol; 2007; 53(6):674-6. PubMed ID: 18416136 [TBL] [Abstract][Full Text] [Related]
11. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study. Esposito NN; Chivukula M; Dabbs DJ Mod Pathol; 2007 Jan; 20(1):130-8. PubMed ID: 17143261 [TBL] [Abstract][Full Text] [Related]
12. Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma. Sentani K; Tashiro T; Oue N; Yasui W APMIS; 2007 Dec; 115(12):1422-5. PubMed ID: 18184414 [No Abstract] [Full Text] [Related]
14. Improving outcomes for patients with hormone receptor-positive breast cancer: back to the drawing board. Ellis MJ J Natl Cancer Inst; 2008 Feb; 100(3):159-61. PubMed ID: 18230793 [No Abstract] [Full Text] [Related]
15. High prevalence of HER-2/neu overexpression among Iranian women with breast cancer: true or false? Saatee S; Afrakhteh M; Sadrolhefazi B Breast J; 2006; 12(5):499-501. PubMed ID: 16958978 [No Abstract] [Full Text] [Related]
16. Orbital tumour as a presenting symptom of breast carcinoma: value of detecting hormone receptors. Sekundo W; Vogel J Eye (Lond); 1997; 11 ( Pt 4)():560-3. PubMed ID: 9425424 [TBL] [Abstract][Full Text] [Related]
18. Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies. Mangili F; Sassi I; Di Rocco M; Leone BE; Garancini P; Santambrogio G Cancer; 1996 Dec; 78(11):2334-9. PubMed ID: 8941003 [TBL] [Abstract][Full Text] [Related]
19. [Prognostic and predictive factors in breast cancer]. Bozhok AA; Semiglazov VF; Semiglazov VV; Arzumanov AS; Klettsel' AE Vopr Onkol; 2005; 51(4):434-43. PubMed ID: 16308974 [TBL] [Abstract][Full Text] [Related]
20. Pure or mixed-type invasive lobular carcinoma? Bulut N; Dede DS; Sari E; Altundag K Hum Pathol; 2008 Jul; 39(7):1121; author reply 1121. PubMed ID: 18570979 [No Abstract] [Full Text] [Related] [Next] [New Search]